Literature DB >> 9368710

Effects of mistletoe lectin I on human blood cell lines and peripheral blood cells. Cytotoxicity, apoptosis and induction of cytokines.

B Möckel1, T Schwarz, H Zinke, J Eck, M Langer, H Lentzen.   

Abstract

The effects of mistletoe lectin I (ML I) on the human T-cell leukemia line MOLT-4, the monocytic line THP-1 and on human peripheral blood mononuclear cells (PBMC) were investigated with regard to general cell viability and induction of apoptosis. Using a sensitive serum-free cytotoxicity assay, the time- and concentration-dependent direct toxicity towards MOLT-4 cells was determined with IC50-values ranging from 20-40 pg/ml (300-600 fmol/l). Investigations on the time course of the toxic effect using selected concentrations of ML I revealed distinct response curves for concentrations of high, low and intermediate toxicity, respectively. The ratio of apoptotic to viable MOLT-4 cells was determined after treatment with ML I for 24 h. Apoptosis and cytotoxicity were correlated at low and intermediate concentrations, whereas at long intervals and high concentrations of ML I mostly necrotic effects were observed. The data showed that in the concentration range of low cytotoxicity ML I-induced cell death is quantitatively due to apoptotic processes. The immunomodulatory activity of ML I was investigated in vitro by measuring cytokine release. At concentrations of low cytotoxicity ML I showed immunostimulatory activity on PBMC and THP-1. RT-PCR with THP-1 cells confirmed that cytokine induction by ML I is regulated on the transcriptional level. These findings suggest that in the blood cells investigated both apoptosis and cellular signalling are induced by the same concentration range of ML I.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9368710

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  7 in total

1.  Biological effects of natural and recombinant mistletoe lectin and an aqueous mistletoe extract on human monocytes and lymphocytes in vitro.

Authors:  U Elsässer-Beile; M Voss; R Schühle; U Wetterauer
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Active Chinese mistletoe lectin-55 enhances colon cancer surveillance through regulating innate and adaptive immune responses.

Authors:  Yan-Hui Ma; Wei-Zhi Cheng; Fang Gong; An-Lun Ma; Qi-Wen Yu; Ji-Ying Zhang; Chao-Ying Hu; Xue-Hua Chen; Dong-Qing Zhang
Journal:  World J Gastroenterol       Date:  2008-09-14       Impact factor: 5.742

3.  Interaction of standardized mistletoe (Viscum album) extracts with chemotherapeutic drugs regarding cytostatic and cytotoxic effects in vitro.

Authors:  Ulrike Weissenstein; Matthias Kunz; Konrad Urech; Stephan Baumgartner
Journal:  BMC Complement Altern Med       Date:  2014-01-08       Impact factor: 3.659

4.  Mistletoe extract Fraxini inhibits the proliferation of liver cancer by down-regulating c-Myc expression.

Authors:  Peiying Yang; Yan Jiang; Yong Pan; Xiaoping Ding; Patrea Rhea; Jibin Ding; David H Hawke; Dean Felsher; Goutham Narla; Zhimin Lu; Richard T Lee
Journal:  Sci Rep       Date:  2019-04-23       Impact factor: 4.379

5.  Antiamylase, Antilipase, Antimicrobial, and Cytotoxic Activity of Nonea obtusifolia (Willd.) DC. from Palestine.

Authors:  Nidal Jaradat; Murad N Abualhasan; Mohammad Qadi; Linda Issa; Ahmad Mousa; Fathia Allan; Mohammad Hindi; Zaid Alhrezat
Journal:  Biomed Res Int       Date:  2020-12-01       Impact factor: 3.411

6.  A Randomized Study on Postrelapse Disease-Free Survival with Adjuvant Mistletoe versus Oral Etoposide in Osteosarcoma Patients.

Authors:  Alessandra Longhi; Marcus Reif; Erminia Mariani; Stefano Ferrari
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-31       Impact factor: 2.629

7.  European Mistletoe (Viscum album) Extract Is Cytotoxic to Canine High-Grade Astrocytoma Cells In Vitro and Has Additive Effects with Mebendazole.

Authors:  Anna Wright; Rie Watanabe; Jey W Koehler
Journal:  Vet Sci       Date:  2022-01-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.